CreditReports.dk
HomeScreen companies

MiNA Therapeutics Denmark ApS Financials, key figures and credit report

CVR number: 43329545 Established 2022 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Frederikskaj 10 B, 2450 København SV
Gross profit 4 727.4 kDKK FY 2024 -58.3% vs 2023
EBIT 503.4 kDKK FY 2024 -92.7% vs 2023
Net debt 2 595.8 kDKK FY 2024
Quick ratio 3.3 FY 2024 +1.6 vs 2023

Company information

Official name
MiNA Therapeutics Denmark ApS
Personnel
2 persons
Established
2022
Company form
Private limited company
Industry

Data sources and methodology

The information about MiNA Therapeutics Denmark ApS combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.

Company information

Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).

CVR / Virk

Annual accounts

Financial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2024.

Open the 2024 annual report

Key figures and credit risk

Valuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.

Valuatum Oy

About MiNA Therapeutics Denmark ApS

MiNA Therapeutics Denmark ApS (CVR number: 4332954-5) is a company from KØBENHAVN. The company recorded a gross profit of 4727.4 kDKK in 2024. The operating profit was 503.4 kDKK, while net earnings were 372.5 kDKK. The profitability of the company measured by Return on Assets (ROA) was 12.5 %, which can be considered good but Return on Equity (ROE) was 33.9 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 21.1 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. MiNA Therapeutics Denmark ApS's liquidity measured by quick ratio was 3.3 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.

Financial information

See financials

Gross profit (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
2022
2023
2024
Volume
Net sales
Gross profit-1 014.4511 343.384 727.43
EBIT-5 751.766 874.86503.40
Net earnings-5 752.976 623.98372.51
Shareholders equity total-5 712.97911.001 283.51
Balance sheet total (assets)399.922 142.076 068.62
Net debt5 405.912 595.78
Profitability
EBIT-%
ROA-94.1 %166.6 %12.5 %
ROE-1 438.5 %1 010.6 %33.9 %
ROI- 106.4 %217.7 %20.0 %
Economic value added (EVA)-5 751.766 642.67340.24
Solvency
Equity ratio-93.5 %42.5 %21.1 %
Gearing-94.6 %230.2 %
Relative net indebtedness %
Liquidity
Quick ratio0.51.73.3
Current ratio0.51.73.3
Cash and cash equivalents358.70
Capital use efficiency
Trade debtors turnover (days)
Net working capital %

Variable visualization

ROA FY 2024
12.5%
Rating 62/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio FY 2024
21.1%
Rating 20/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Credit Risk Report

Affordable credit risk report
for basic company risk checks.

Check the creditworthiness of MiNA Therapeutics Denmark ApS before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.

AI Credit Risk Report

The core credit-risk figures,
explained with AI.

The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.

  1. 01 Includes the same financial figures, risk scores, credit rating and bankruptcy risk as the Credit Risk Report.
  2. 02 AI complements the analysis with web searches and brings in the relevant company and operating-environment observations.
  3. 03 The written analysis is more precise, more readable and better suited to decision-making.
€3 / report

Company-specific, AI-assisted credit risk report in PDF format.

For larger customers

Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk

The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.

What the report includes

8 sections
Financial figures
Risk scores
Credit rating
Bankruptcy risk
AI web-search highlights
Written risk analysis
Conclusions
Ratio appendices

Companies in the same industry

Page generated